News
09-12-2011, 06:50 AM
BioSante Pharmaceuticals, Inc., today announced successful completion of its principal LibiGel (testosterone gel) pharmacokinetic (PK) study.
More... (http://www.news-medical.net/news/20110912/BioSante-reports-top-line-results-from-LibiGel-PK-study-for-HSDD-in-postmenopausal-women.aspx)
More... (http://www.news-medical.net/news/20110912/BioSante-reports-top-line-results-from-LibiGel-PK-study-for-HSDD-in-postmenopausal-women.aspx)